Evidence map›Paper›PMID 34145438›Full record

ArticleLab animal2021

Constructing and programming a cost-effective murine running wheel with digital revolution counter.

Jared Edwards, Brennan Olson, Daniel L Marks

Abstract read
In one paragraph

Article in Lab animal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jared Edwards *Department of General Surgery, Naval Medical Center San Diego, San Diego, CA, USA.ORCID 0000-0002-9108-3854
Brennan Olson *Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA.
Daniel L MarksPapé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA. marksd@ohsu.edu.ORCID 0000-0003-2675-7047

Funding

Exosomes as Endocrine Signaling Molecules in Cancer CachexiaR01CA217989 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI MARKS, DANIEL L. · 2018 to 2022
$2.2M
PQ6: Lipocalin-2 as a therapeutic target for prevention of cancer cachexiaR01CA257452 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ZIMMERS, TERESA A · 2021 to 2025
$1.9M
(PQD6) Hypothalamic Inflammation in the Initiation of CachexiaR01CA184324 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI MARKS, DANIEL L. · 2014 to 2017
$1.8M
The Role of Lipocalin 2 in Cancer CachexiaF30CA254033 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI OLSON, BRENNAN GLENN · 2020 to 2021
$97k
NCI NIH HHS F30 CA254033NCI NIH HHS R01 CA184324NCI NIH HHS R01 CA217989NCI NIH HHS R01 CA257452
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Physical Conditioning, AnimalAnimalsCost-Benefit AnalysisEatingMice

Identifiers

PMID34145438
PMCPMC10998480

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.